FEMSelect Ltd.

femselect.com

Formerly ProAccess, POP Medical

High-Tech Company

Graduated from: RAD BioMed

TAGS

FemTech, Gynecology

General Data

Sector	Life Sciences
Sub-Sector	Medical Devices

TECHNOLOGY

FEMSelect is a developer of minimally invasive uterine prolapse system. The company's product, EnPlace, is a surgical system for suturing ligaments of the pelvic floor for Pelvic Organ Prolapse (POP), and is a combination of a nitinol-based...(Unlock More)...

CONTACT INFO

Personal Contact Information

Blog

Expand / Collapse All

	MANAGEMENT

Key Executive

	BOARD

Board

	FINANCIAL ROUNDS

Round

Date

Stage

Amount

Valuation

Second Round

Oct. 19, 2022

Initial Revenues

$9m

N/A

General Info

Angel Company & Title
E-mail
Website
No. of Current Portfolio Companies
Remarks

Business Description

Description
Angel Activity

Investment Data

Managed Capital
Capital Remarks
Capital Available

Preferences

Maximum investments
Minimum investments
Type of Financing
Stage Preferences
Phase Preferences
Industry Preferences

	SECTOR SEGMENTATION (By Number Of Companies)

Current Israeli Clients (#)

	Deals Underwritten (#)

	Deals Legally Advised (#)

	Current Positions

	Previous Positions

	Background

	Education

	Specialties

Last Updated: Apr 25, 2024